Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-004800-71Phase 2Completed
Phase 2, open-label trial of cefoxitin in Cardiovascular Malformation (CVM) (4 arms), sponsored by Ospedale Pediatrico Bambino Gesù. Primary endpoint: Intraoperative cefoxitin blood levels. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-004800-71.